YAP1 and neoplasm: (128) recently discovered that YAP1 can regulate the phenotype of CAFs, which can transform CAFs from the tumor-promoting subtype that promotes ECM deposition to the tumor-suppressing subtype that stimulates anti-tumor immunity, thereby increasing the treatment sensitivity of immune-checkpoint blockade.